Does omalizumab treatment treat chronic hives?

Chronic spontaneous urticaria causes recurring itchy wheals, with or without deeper swelling, without an identifiable external trigger in many cases. Omalizumab is a prescription biologic given by injection. It targets immunoglobulin E, a messenger involved in allergic-type immune signalling, and can reduce the tendency for mast cells to release substances that drive hives.

The response differs between people. Omalizumab controls symptoms rather than guaranteeing that the underlying tendency has ended. Hives can return when treatment is delayed or stopped, so the plan should be reviewed with the prescribing clinician.

A specialist will confirm the diagnosis, review previous medicines, and decide whether omalizumab fits your symptoms and medical history. Keep a record of wheals, swelling, possible triggers, and treatment response so adjustments are based on a clear pattern.

Attend injections as scheduled and follow the observation advice provided by the clinic. Tell the team about previous reactions to injections, asthma, pregnancy, and all medicines or supplements. Do not change antihistamines or other treatment without guidance.

Get emergency help for swelling of the tongue or throat, trouble breathing, faintness, or rapidly worsening symptoms. After an injection, report widespread itching, wheezing, dizziness, or facial swelling immediately, as these may signal a serious reaction.

Ask how omalizumab fits your diagnosis, when improvement will be reviewed, what to do if hives break through, and how injections will be monitored.